Publications

ENG

First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.

Abstract

BACKGROUND: Despite World Health Organization (WHO) prequalification of two safe and effective oral cholera vaccines (OCV), concerns about the acceptability, potential diversion of resources, cost and feasibility of implementing timely

Authors: Luquero FJ Grout L Ciglenecki I Sakoba K Traore B Heile M Dialo AA Itama C Serafini M Legros D Grais RF
Journal Reference: PLoS neglected tropical diseases 2013 ; 7(10); e2465. doi: 10.1371/journal.pntd.0002465. Epub 2013 10 17
ENG

Use of a cholera rapid diagnostic test during a mass vaccination campaign in response to an epidemic in Guinea, 2012.

Abstract

BACKGROUND: During the 2012 cholera outbreak in the Republic of Guinea, the Ministry of Health, supported by Médecins Sans Frontières - Operational Center Geneva, used the oral cholera vaccine Shanchol as a part of the emergency respon

Authors: Martinez-Pino I Luquero FJ Sakoba K Sylla S Haile M Grais RF Ciglenecki I Quilici ML Page AL
Journal Reference: PLoS neglected tropical diseases 2013 ; 7(8); e2366. doi: 10.1371/journal.pntd.0002366. Epub 2013 08 15
ENG

Task-sharing of HIV care and ART initiation: evaluation of a mixed-care non-physician provider model for ART delivery in rural Malawi.

Abstract

BACKGROUND: Expanding access to antiretroviral therapy (ART) in sub-Saharan Africa requires implementation of alternative care delivery models to traditional physician-centered approaches.

Authors: McGuire M Ben Farhat J Pedrono G Szumilin E Heinzelmann A Chinyumba YN Goossens S Makombe S Pujades-Rodríguez M
Journal Reference: PloS one 2013 ; 8(9); e74090. doi: 10.1371/journal.pone.0074090. Epub 2013 09 16
ENG

Infections in children admitted with complicated severe acute malnutrition in Niger.

Abstract

BACKGROUND: Although malnutrition affects thousands of children throughout the Sahel each year and predisposes them to infections, there is little data on the etiology of infections in these populations.

Authors: Page AL de Rekeneire N Sayadi S Aberrane S Janssens AC Rieux C Djibo A Manuguerra JC Ducou-le-Pointe H Grais RF Schaefer M Guerin PJ Baron E
Journal Reference: PloS one 2013 ; 8(7); e68699. doi: 10.1371/journal.pone.0068699. Epub 2013 07 17
ENG

Malaria is an uncommon cause of adult sepsis in south-western Uganda.

Abstract

BACKGROUND: Malaria is often considered a cause of adult sepsis in malaria endemic areas. However, diagnostic limitations can make distinction between malaria and other infections challenging.

Authors: Auma MA Siedner MJ Nyehangane D Nalusaji A Nakaye M Mwanga-Amumpaire J Muhindo R Wilson LA Boum Y Moore CC
Journal Reference: Malaria journal 2013 May 01; 12(); 146. doi: 10.1186/1475-2875-12-146. Epub 2013 05 01
ENG

Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment.

Abstract

BACKGROUND: Malaria in pregnancy (MiP) is a major public health problem in endemic areas of sub-Saharan Africa and has important consequences on birth outcome.

Authors: De Beaudrap P Turyakira E White LJ Nabasumba C Tumwebaze B Muehlenbachs A Guérin PJ Boum Y McGready R Piola P
Journal Reference: Malaria journal 2013 Apr 24; 12(); 139. doi: 10.1186/1475-2875-12-139. Epub 2013 04 24
ENG

Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.

Abstract

BACKGROUND: In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, ide

Authors: Gabillard D Lewden C Ndoye I Moh R Segeral O Tonwe-Gold B Etard JF Pagnaroat M Fournier-Nicolle I Eholié S Konate I Minga A Mpoudi-Ngole E Koulla-Shiro S Zannou DM Anglaret X Laurent C
Journal Reference: Journal of acquired immune deficiency syndromes (1999) 2013 Apr 15; 62(5); 555-61. doi: 10.1097/QAI.0b013e3182821821. Epub 2013 10 18
ENG

Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.

Abstract

BACKGROUND: In countries with a high incidence of HIV and tuberculosis co-infection, nevirapine and efavirenz are widely used as antiretroviral therapy but both interact with antituberculosis drugs.

Authors: Bonnet M Bhatt N Baudin E Silva C Michon C Taburet AM Ciaffi L Sobry A Bastos R Nunes E Rouzioux C Jani I Calmy A
Journal Reference: The Lancet. Infectious diseases 2013 Apr ; 13(4); 303-12. doi: 10.1016/S1473-3099(13)70007-0. Epub 2013 02 20
ENG

Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.

Abstract

For over 100 years, large epidemics of meningococcal meningitis have occurred every few years in areas of the African Sahel and sub-Sahel known as the African meningitis belt.

Authors: Altmann D Aseffa A Bash M Basta N Borrow R Broome C Caugant D Clark T Collard JM Djingarey M Goldblatt D Greenwood B Griffiths U Hajjeh R Hassan-King M Hugonnet S Kimball AM LaForce M MacLennan C Maiden MC Manigart O Mayer L Messonnier N Moisi J Moore K Moto DD Mueller J Nascimento M Obaro S Ouedraogo R Page AL Perea W Pluschke G Preziosi MP Sow S Stephens D Stuart J Thomson M Tiendrebeogo S Trape JF Vernet G
Journal Reference: Vaccine 2013 Mar 01; 31(11); 1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 12 27